{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T03:29:17Z","timestamp":1767410957755,"version":"3.48.0"},"reference-count":89,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.2169\/internalmedicine.4711-24","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T17:13:05Z","timestamp":1732122785000},"page":"11-22","source":"Crossref","is-referenced-by-count":0,"title":["Heart Regeneration for Clinical Application"],"prefix":"10.2169","volume":"65","author":[{"given":"Hidenori","family":"Tani","sequence":"first","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Japan"},{"name":"Department of Prevention Center, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ieda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. The Japanese Society for Heart Transplantation. The registry report of Japanese heart Transplantation-2023. Ishoku 58: 209-217, 2023."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147, 1998.","DOI":"10.1126\/science.282.5391.1145"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676, 2006.","DOI":"10.1016\/j.cell.2006.07.024"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Tohyama S, Hattori F, Sano M, et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12: 127-137, 2013.","DOI":"10.1016\/j.stem.2012.09.013"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tohyama S, Fujita J, Hishiki T, et al. Glutamine oxidation is indispensable for survival of human pluripotent stem cells. Cell Metab 23: 663-674, 2016.","DOI":"10.1016\/j.cmet.2016.03.001"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Tohyama S, Fujita J, Fujita C, et al. Efficient large-scale 2D culture system for human induced pluripotent stem cells and differentiated cardiomyocytes. Stem Cell Reports 9: 1406-1414, 2017.","DOI":"10.1016\/j.stemcr.2017.08.025"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tabei R, Kawaguchi S, Kanazawa H, et al. Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cellderived cardiomyocytes. J Heart Lung Transplant 38: 203-214, 2019.","DOI":"10.1016\/j.healun.2018.11.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kawaguchi S, Soma Y, Nakajima K, et al. Intramyocardial transplantation of human iPS cell-derived cardiac spheroids improves cardiac function in heart failure animals. JACC Basic Transl Sci 6: 239-254, 2021.","DOI":"10.1016\/j.jacbts.2020.11.017"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Tanosaki S, Tohyama S, Fujita J, et al. Fatty acid synthesis is indispensable for survival of human pluripotent stem cells. iScience 23: 101535, 2020.","DOI":"10.1016\/j.isci.2020.101535"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tani H, Tohyama S, Kishino Y, Kanazawa H, Fukuda K. Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy. J Mol Cell Cardiol 164: 83-91, 2022.","DOI":"10.1016\/j.yjmcc.2021.11.008"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142: 375-386, 2010.","DOI":"10.1016\/j.cell.2010.07.002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Inagawa K, Miyamoto K, Yamakawa H, et al. Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5. Circ Res 111: 1147-1156, 2012.","DOI":"10.1161\/CIRCRESAHA.112.271148"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Wada R, Muraoka N, Inagawa K, et al. Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. Proc Natl Acad Sci U S A 110: 12667-12672, 2013.","DOI":"10.1073\/pnas.1304053110"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Muraoka N, Yamakawa H, Miyamoto K, et al. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. EMBO J 33: 1565-1581, 2014.","DOI":"10.15252\/embj.201387605"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Yamakawa H, Muraoka N, Miyamoto K, et al. Fibroblast growth factors and vascular endothelial growth factor promote cardiac reprogramming under defined conditions. Stem Cell Reports 5: 1128-1142, 2015.","DOI":"10.1016\/j.stemcr.2015.10.019"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Miyamoto K, Akiyama M, Tamura F, et al. Direct in vivo reprogramming with sendai virus vectors improves cardiac function after myocardial infarction. Cell Stem Cell 22: 91-103.e5, 2018.","DOI":"10.1016\/j.stem.2017.11.010"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Muraoka N, Nara K, Tamura F, et al. Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming. Nat Commun 10: 674, 2019.","DOI":"10.1038\/s41467-019-08626-y"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Kurotsu S, Sadahiro T, Fujita R, et al. Soft matrix promotes cardiac reprogramming via inhibition of YAP\/TAZ and suppression of fibroblast signatures. Stem Cell Reports 15: 612-628, 2020.","DOI":"10.1016\/j.stemcr.2020.07.022"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Isomi M, Sadahiro T, Yamakawa H, et al. Overexpression of Gata4, Mef2c, and Tbx5 generates induced cardiomyocytes via direct reprogramming and rare fusion in the heart. Circulation 143: 2123-2125, 2021.","DOI":"10.1161\/CIRCULATIONAHA.120.052799"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Kojima H, Sadahiro T, Muraoka N, et al. MEF2C\/p300-mediated epigenetic remodeling promotes the maturation of induced cardiomyocytes. Stem Cell Reports 18: 1274-1283, 2023.","DOI":"10.1016\/j.stemcr.2023.05.001"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Tani H, Sadahiro T, Yamada Y, et al. Direct reprogramming improves cardiac function and reverses fibrosis in chronic myocardial infarction. Circulation 147: 223-238, 2023.","DOI":"10.1161\/CIRCULATIONAHA.121.058655"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Abe Y, Tani H, Sadahiro T, et al. Cardiac reprogramming reduces inflammatory macrophages and improves cardiac function in chronic myocardial infarction. Biochem Biophys Res Commun 1: 690, 2024.","DOI":"10.1016\/j.bbrc.2023.149272"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hentze H, Soong PL, Wang ST, Phillips BW, Putti TC, Dunn NR. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res 2: 198-210, 2009.","DOI":"10.1016\/j.scr.2009.02.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Murry CE, Reinecke H, Pabon LM. Regeneration gaps. observations on stem cells and cardiac repair. J Am Coll Cardiol 47: 1777-1785, 2006.","DOI":"10.1016\/j.jacc.2006.02.002"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Regent F, Morizur L, Lesueur L, et al. Automation of human pluripotent stem cell differentiation toward retinal pigment epithelial cells for large-scale productions. Sci Rep 9: 10646, 2019.","DOI":"10.1038\/s41598-019-47123-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kanda GN, Tsuzuki T, Terada M, et al. Robotic search for optimal cell culture in regenerative medicine. Elife 11: 2022.","DOI":"10.7554\/eLife.77007"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Shimizu T, Yamato M, Isoi Y, et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90: 2002.","DOI":"10.1161\/hh0302.105722"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kawamura M, Miyagawa S, Miki K, et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126 (11 suppl 1): S29-S37, 2012.","DOI":"10.1161\/CIRCULATIONAHA.111.084343"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Tiburcy M, Hudson JE, Balfanz P, et al. Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair. Circulation 135: 1832-1847, 2017.","DOI":"10.1161\/CIRCULATIONAHA.116.024145"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Querdel E, Reinsch M, Castro L, et al. Human engineered heart tissue patches remuscularize the injured heart in a dose-dependent manner. Circulation 143: 1991-2006, 2021.","DOI":"10.1161\/CIRCULATIONAHA.120.047904"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Gerbin KA, Yang X, Murry CE, Coulombe KL. Enhanced electrical integration of engineered human myocardium via intramyocardial versus epicardial delivery in infarcted rat hearts. PLoS One 10: e0131446, 2015.","DOI":"10.1371\/journal.pone.0131446"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Higuchi T, Miyagawa S, Pearson JT, et al. Functional and electrical integration of induced pluripotent stem cell-derived cardiomyocytes in a myocardial infarction rat heart. Cell Transplant 24: 2479-2489, 2015.","DOI":"10.3727\/096368914X685799"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25: 1015-1024, 2007.","DOI":"10.1038\/nbt1327"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Chong JJH, Yang X, Don CW, et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510: 273-277, 2014.","DOI":"10.1038\/nature13233"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Shiba Y, Fernandes S, Zhu WZ, et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489: 322-325, 2012.","DOI":"10.1038\/nature11317"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Shiba Y, Gomibuchi T, Seto T, et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 538: 388-391, 2016.","DOI":"10.1038\/nature19815"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Liu YW, Chen B, Yang X, et al. Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates. Nat Biotechnol 36: 597-605, 2018.","DOI":"10.1038\/nbt.4162"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39. Tani H, Tohyama S. Human engineered heart tissue models for disease modeling and drug discovery. Front Cell Dev Biol 10: 855763, 2022.","DOI":"10.3389\/fcell.2022.855763"},{"key":"39","doi-asserted-by":"publisher","unstructured":"40. Ronaldson-Bouchard K, Ma SP, Yeager K, et al. Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature 556: 239-243, 2018.","DOI":"10.1038\/s41586-018-0016-3"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41. Cho GS, Lee DI, Tampakakis E, et al. Neonatal transplantation confers maturation of PSC-derived cardiomyocytes conducive to modeling cardiomyopathy. Cell Rep 18: 571-582, 2017.","DOI":"10.1016\/j.celrep.2016.12.040"},{"key":"41","doi-asserted-by":"publisher","unstructured":"42. Kadota S, Pabon L, Reinecke H, Murry CE. In vivo maturation of human induced pluripotent stem cell-derived cardiomyocytes in neonatal and adult rat hearts. Stem Cell Reports 8: 278-289, 2017.","DOI":"10.1016\/j.stemcr.2016.10.009"},{"key":"42","doi-asserted-by":"publisher","unstructured":"43. Nakamura K, Neidig LE, Yang X, et al. Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes. Stem Cell Reports 16: 2473-2487, 2021.","DOI":"10.1016\/j.stemcr.2021.08.005"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44. Kobayashi H, Tohyama S, Kanazawa H, et al. Intracoronary transplantation of pluripotent stem cell-derived cardiomyocytes: inefficient procedure for cardiac regeneration. J Mol Cell Cardiol 174: 77-87, 2023.","DOI":"10.1016\/j.yjmcc.2022.11.004"},{"key":"44","doi-asserted-by":"publisher","unstructured":"45. Tani H, Kobayashi E, Yagi S, et al. Heart-derived collagen promotes maturation of engineered heart tissue. Biomaterials 299: 122174, 2023.","DOI":"10.1016\/j.biomaterials.2023.122174"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46. Zhang J, Li J, Qu X, et al. Development of composite functional tissue sheets using hiPSC-CMs and hADSCs to improve the cardiac function after myocardial infarction. Bioact Mater 37: 533-548, 2024.","DOI":"10.1016\/j.bioactmat.2024.03.028"},{"key":"46","doi-asserted-by":"crossref","unstructured":"47. Wu K, Wang Y, Yang H, et al. Injectable decellularized extracellular matrix hydrogel containing stromal cell-derived factor 1 promotes transplanted cardiomyocyte engraftment and functional regeneration after myocardial infarction. ACS Appl Mater Interfaces 15: 2578-2589, 2023.","DOI":"10.1021\/acsami.2c16682"},{"key":"47","doi-asserted-by":"crossref","unstructured":"48. Wang L, Chen P, Pan Y, et al. Injectable photocurable Janus hydrogel delivering hiPSC cardiomyocyte-derived exosome for post-heart surgery adhesion reduction. Sci Adv 9: eadh1753, 2023.","DOI":"10.1126\/sciadv.adh1753"},{"key":"48","unstructured":"49. Selvakumar D, Clayton ZE, Prowse A, et al. Cellular heterogeneity of pluripotent stem cell-derived cardiomyocyte grafts is mechanistically linked to treatable arrhythmias. Nat Cardiovasc Res 3: 145-165, 2024."},{"key":"49","doi-asserted-by":"publisher","unstructured":"50. Marchiano S, Nakamura K, Reinecke H, et al. Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy. Cell Stem Cell 30: 396-414.e9, 2023.","DOI":"10.1016\/j.stem.2023.03.010"},{"key":"50","doi-asserted-by":"publisher","unstructured":"51. Kobayashi H, Tohyama S, Ichimura H, et al. Regeneration of nonhuman primate hearts with human induced pluripotent stem cell-derived cardiac spheroids. Circulation 150: 611-621, 2024.","DOI":"10.1161\/CIRCULATIONAHA.123.064876"},{"key":"51","doi-asserted-by":"publisher","unstructured":"52. Yoshida S, Kato TM, Sato Y, et al. A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population. Med 4: 51-66.e10, 2023.","DOI":"10.1016\/j.medj.2022.10.003"},{"key":"52","doi-asserted-by":"crossref","unstructured":"53. De Almeida PE, Ransohoff JD, Nahid A, Wu JC. Immunogenicity of pluripotent stem cells and their derivatives. Circ Res 112: 549-561, 2013.","DOI":"10.1161\/CIRCRESAHA.111.249243"},{"key":"53","doi-asserted-by":"publisher","unstructured":"54. Riolobos L, Hirata RK, Turtle CJ, et al. HLA engineering of human pluripotent stem cells. Molecular Therapy 21: 1232-1241, 2013.","DOI":"10.1038\/mt.2013.59"},{"key":"54","doi-asserted-by":"crossref","unstructured":"55. Desandro A, Nagarajan UM, Boss JM. The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes. Am J Hum Genet 65: 279-286, 1999.","DOI":"10.1086\/302519"},{"key":"55","doi-asserted-by":"crossref","unstructured":"56. Wang D, Quan Y, Yan Q, Morales JE, Wetsel RA. Targeted disruption of the \u03b22-microglobulin gene minimizes the immunogenicity of human embryonic stem cells. Stem Cells Transl Med 4: 1234-1245, 2015.","DOI":"10.5966\/sctm.2015-0049"},{"key":"56","doi-asserted-by":"crossref","unstructured":"57. Gornalusse GG, Hirata RK, Funk SE, et al. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nat Biotechnol 35: 765-772, 2017.","DOI":"10.1038\/nbt.3860"},{"key":"57","doi-asserted-by":"crossref","unstructured":"58. Han X, Wang M, Duan S, et al. Generation of hypoimmunogenic human pluripotent stem cells. Proc Nat Acad Sci 116: 10441-10446, 2019.","DOI":"10.1073\/pnas.1902566116"},{"key":"58","doi-asserted-by":"publisher","unstructured":"59. Xu H, Wang B, Ono M, et al. Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24: 566-578.e7, 2019.","DOI":"10.1016\/j.stem.2019.02.005"},{"key":"59","doi-asserted-by":"crossref","unstructured":"60. Fernandes S, Naumova AV, Zhu WZ, Laflamme MA, Gold J, Murry CE. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J Mol Cell Cardiol 49: 941-949, 2010.","DOI":"10.1016\/j.yjmcc.2010.09.008"},{"key":"60","doi-asserted-by":"crossref","unstructured":"61. Shiba Y, Filice D, Fernandes S, et al. Electrical integration of human embryonic stem cell-derived cardiomyocytes in a guinea pig chronic infarct model. J Cardiovasc Pharmacol Ther 19: 368-381, 2014.","DOI":"10.1177\/1074248413520344"},{"key":"61","doi-asserted-by":"publisher","unstructured":"62. Lin Y, Sato N, Hong S, et al. Long-term engraftment and maturation of autologous iPSC-derived cardiomyocytes in two rhesus macaques. Cell Stem Cell 31: 974-988, 2024.","DOI":"10.1016\/j.stem.2024.05.005"},{"key":"62","doi-asserted-by":"publisher","unstructured":"63. Romagnuolo R, Masoudpour H, Porta-S\u00e1nchez A, et al. Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias. Stem Cell Reports 12: 967-981, 2019.","DOI":"10.1016\/j.stemcr.2019.04.005"},{"key":"63","doi-asserted-by":"crossref","unstructured":"64. Suzuki K, Miyagawa S, Liu L, et al. Therapeutic efficacy of large aligned cardiac tissue derived from induced pluripotent stem cell in a porcine ischemic cardiomyopathy model. J Heart Lung Transplant 40: 767-777, 2021.","DOI":"10.1016\/j.healun.2021.04.010"},{"key":"64","doi-asserted-by":"publisher","unstructured":"65. Ishida M, Miyagawa S, Saito A, et al. Transplantation of human-induced pluripotent stem cell-derived cardiomyocytes is superior to somatic stem cell therapy for restoring cardiac function and oxygen consumption in a porcine model of myocardial infarction. Transplantation 103: 291-298, 2019.","DOI":"10.1097\/TP.0000000000002384"},{"key":"65","doi-asserted-by":"crossref","unstructured":"66. Vo QD, Saito Y, Nakamura K, Iida T, Yuasa S. Induced pluripotent stem cell-derived cardiomyocytes therapy for ischemic heart disease in animal model: a meta-analysis. Int J Mol Sci 25: 987, 2024.","DOI":"10.3390\/ijms25020987"},{"key":"66","doi-asserted-by":"crossref","unstructured":"67. Menasche P, Vanneaux V, Hagege A, et al. Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction. J Am Coll Cardiol 71: 429-438, 2018.","DOI":"10.1016\/j.jacc.2017.11.047"},{"key":"67","doi-asserted-by":"crossref","unstructured":"68. Miyagawa S, Kainuma S, Kawamura T, et al. Case report: transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy. Front Cardiovasc Med 9: 950829, 2022.","DOI":"10.3389\/fcvm.2022.950829"},{"key":"68","doi-asserted-by":"crossref","unstructured":"69. Eschenhagen T, Weinberger F. Challenges and perspectives of heart repair with pluripotent stem cell-derived cardiomyocytes. Nat Cardiovasc Res 3: 515-524, 2024.","DOI":"10.1038\/s44161-024-00472-6"},{"key":"69","doi-asserted-by":"publisher","unstructured":"70. Qian L, Huang Y, Spencer CI, et al. <i>In vivo<\/i> reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485: 593-598, 2012.","DOI":"10.1038\/nature11044"},{"key":"70","doi-asserted-by":"publisher","unstructured":"71. Song K, Nam YJ, Luo X, et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485: 599-604, 2012.","DOI":"10.1038\/nature11139"},{"key":"71","doi-asserted-by":"crossref","unstructured":"72. Jayawardena TM, Egemnazarov B, Finch EA, et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res 110: 1465-1473, 2012.","DOI":"10.1161\/CIRCRESAHA.112.269035"},{"key":"72","doi-asserted-by":"crossref","unstructured":"73. Jayawardena TM, Finch EA, Zhang L, et al. MicroRNA induced cardiac reprogramming in vivo evidence for mature cardiac myocytes and improved cardiac function. Circ Res 116: 418-424, 2014.","DOI":"10.1161\/CIRCRESAHA.116.304510"},{"key":"73","doi-asserted-by":"crossref","unstructured":"74. Zhao Y, Londono P, Cao Y, et al. High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling. Nat Commun 10: 6, 2015.","DOI":"10.1038\/ncomms9243"},{"key":"74","doi-asserted-by":"publisher","unstructured":"75. Mohamed TMA, Stone NR, Berry EC, et al. Chemical enhancement of in vitro and in vivo direct cardiac reprogramming. Circulation 135: 978-995, 2017.","DOI":"10.1161\/CIRCULATIONAHA.116.024692"},{"key":"75","doi-asserted-by":"crossref","unstructured":"76. Hashimoto H, Olson EN, Bassel-Duby R. Therapeutic approaches for cardiac regeneration and repair. Nat Rev Cardiol 15: 585-600, 2018.","DOI":"10.1038\/s41569-018-0036-6"},{"key":"76","doi-asserted-by":"crossref","unstructured":"77. Wang H, Yang J, Cai Y, Zhao Y. Macrophages suppress cardiac reprogramming of fibroblasts <i>in vivo<\/i> via IFN-mediated intercellular self-stimulating circuit. Protein Cell 15: 906-929, 2024.","DOI":"10.1093\/procel\/pwae013"},{"key":"77","doi-asserted-by":"crossref","unstructured":"78. Yoo SY, Jeong SN, Kang JI, Lee SW. Chimeric adeno-associated virus-mediated cardiovascular reprogramming for ischemic heart disease. ACS Omega 3: 5918-5925, 2018.","DOI":"10.1021\/acsomega.8b00904"},{"key":"78","doi-asserted-by":"crossref","unstructured":"79. Zhou H, Yang J, Srinath C, et al. Improved cardiac function in postischemic rats using an optimized cardiac reprogramming cocktail delivered in a single novel adeno-associated virus. Circulation 148: 1099-1112, 2023.","DOI":"10.1161\/CIRCULATIONAHA.122.061542"},{"key":"79","doi-asserted-by":"crossref","unstructured":"80. Chang Y, Lee E, Kim J, Kwon YW, Kwon Y, Kim J. Efficient in vivo direct conversion of fibroblasts into cardiomyocytes using a nanoparticle-based gene carrier. Biomaterials 192: 500-509, 2019.","DOI":"10.1016\/j.biomaterials.2018.11.034"},{"key":"80","doi-asserted-by":"crossref","unstructured":"81. Fu Y, Huang C, Xu X, et al. Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails. Cell Res 25: 1013-1024, 2015.","DOI":"10.1038\/cr.2015.99"},{"key":"81","doi-asserted-by":"crossref","unstructured":"82. Wang J, Wang Q, Cao N. Generation of expandable cardiovascular progenitor cells from mouse and human fibroblasts via direct chemical reprogramming. STAR Protoc 3: 101908, 2022.","DOI":"10.1016\/j.xpro.2022.101908"},{"key":"82","doi-asserted-by":"crossref","unstructured":"83. Morita R, Suzuki M, Kasahara H, et al. ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells. Proc Natl Acad Sci U S A 112: 160-165, 2015.","DOI":"10.1073\/pnas.1413234112"},{"key":"83","doi-asserted-by":"crossref","unstructured":"84. Lee S, Park C, Han JW, et al. Direct reprogramming of human dermal fibroblasts into endothelial cells using ER71\/ETV2. Circ Res 120: 848-861, 2017.","DOI":"10.1161\/CIRCRESAHA.116.309833"},{"key":"84","doi-asserted-by":"crossref","unstructured":"85. Gong W, Das S, Sierra-Pagan JE, et al. ETV2 functions as a pioneer factor to regulate and reprogram the endothelial lineage. Nat Cell Biol 24: 672-684, 2022.","DOI":"10.1038\/s41556-022-00901-3"},{"key":"85","doi-asserted-by":"crossref","unstructured":"86. Cho J, Kim S, Lee H, et al. Regeneration of infarcted mouse hearts by cardiovascular tissue formed via the direct reprogramming of mouse fibroblasts. Nat Biomed Eng 5: 880-896, 2021.","DOI":"10.1038\/s41551-021-00783-0"},{"key":"86","doi-asserted-by":"crossref","unstructured":"87. Farber G, Dong Y, Wang Q, et al. Direct conversion of cardiac fibroblasts into endothelial-like cells using Sox17 and Erg. Nat Commun 15: 4170, 2024.","DOI":"10.1038\/s41467-024-48354-6"},{"key":"87","doi-asserted-by":"crossref","unstructured":"88. Nam YJ, Song K, Luo X, et al. Reprogramming of human fibroblasts toward a cardiac fate. Proc Natl Acad Sci U S A 110: 5588-5593, 2013.","DOI":"10.1073\/pnas.1301019110"},{"key":"88","doi-asserted-by":"publisher","unstructured":"89. Fu JD, Stone NR, Liu L, et al. Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state. Stem Cell Reports 1: 235-247, 2013.","DOI":"10.1016\/j.stemcr.2013.07.005"},{"key":"89","doi-asserted-by":"publisher","unstructured":"90. Zhou Y, Liu Z, Welch JD, et al. Single-cell transcriptomic analyses of cell fate transitions during human cardiac reprogramming. Cell Stem Cell 25: 149-164.e9, 2019.","DOI":"10.1016\/j.stem.2019.05.020"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/1\/65_4711-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T03:26:24Z","timestamp":1767410784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/1\/65_4711-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4711-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"4711-24"}}